Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-44,100
Closed -$4.64M 5293
2025
Q4
$4.64M Buy
44,100
+9,700
+28% +$911K ﹤0.01% 2276
2025
Q3
$2.89M Buy
34,400
+16,800
+95% +$1.38M ﹤0.01% 2596
2025
Q2
$1.39M Sell
17,600
-103,200
-85% -$8.2M ﹤0.01% 3112
2025
Q1
$10.8M Sell
120,800
-26,100
-18% -$2.44M ﹤0.01% 1345
2024
Q4
$14.6M Sell
146,900
-2,700
-2% -$278K ﹤0.01% 1297
2024
Q3
$17M Buy
+149,600
New +$17.8M ﹤0.01% 1146
2024
Q2
Sell
-70,900
Closed -$9.36M 5150
2024
Q1
$9.36M Sell
70,900
-65,100
-48% -$8.02M ﹤0.01% 1442
2023
Q4
$14.8M Buy
+136,000
New +$14.1M 0.01% 1233
2023
Q2
Sell
-340,600
Closed -$36.2M 4888
2023
Q1
$36.2M Sell
340,600
-252,200
-43% -$27.2M 0.02% 607
2022
Q4
$65.8M Buy
592,800
+307,400
+108% +$31.4M 0.03% 384
2022
Q3
$24.6M Buy
285,400
+188,000
+193% +$16.8M 0.03% 545
2022
Q2
$8.88M Buy
97,400
+62,000
+175% +$5.5M 0.01% 1063
2022
Q1
$2.9M Sell
35,400
-8,900
-20% -$702K ﹤0.01% 1583
2021
Q4
$3.4M Sell
44,300
-100,900
-69% -$8.04M ﹤0.01% 1993
2021
Q3
$10.9M Buy
145,200
+40,100
+38% +$3.05M ﹤0.01% 1153
2021
Q2
$8.17M Buy
105,100
+78,795
+300% +$5.86M ﹤0.01% 1302
2021
Q1
$1.94M Sell
26,305
-374,450
-93% -$27.6M ﹤0.01% 2304
2020
Q4
$31.3M Buy
400,755
+276,881
+224% +$21.2M 0.02% 626
2020
Q3
$9.8M Buy
123,874
+29,030
+31% +$2.27M 0.01% 1043
2020
Q2
$7M Sell
94,844
-226,892
-71% -$17.1M 0.01% 1155
2020
Q1
$23.6M Sell
321,736
-393,419
-55% -$30.9M 0.02% 568
2019
Q4
$62.1M Buy
715,155
+180,465
+34% +$14.8M 0.03% 416
2019
Q3
$42.9M Sell
534,690
-173,234
-24% -$13.9M 0.03% 519
2019
Q2
$56.6M Buy
707,924
+482,709
+214% +$37M 0.03% 448
2019
Q1
$17.9M Sell
225,215
-368,582
-62% -$27.6M 0.01% 915
2018
Q4
$43.3M Buy
593,797
+212,535
+56% +$15M 0.03% 429
2018
Q3
$25.8M Sell
381,262
-659,821
-63% -$42M 0.02% 723
2018
Q2
$60.3M Sell
1,041,083
-595,683
-36% -$33.6M 0.05% 315
2018
Q1
$85.1M Sell
1,636,766
-33,222
-2% -$1.79M 0.07% 247
2017
Q4
$89.7M Buy
1,669,988
+1,265,565
+313% +$70.2M 0.07% 220
2017
Q3
$24.7M Sell
404,423
-24,838
-6% -$1.51M 0.03% 576
2017
Q2
$26.3M Buy
429,261
+192,623
+81% +$11.7M 0.03% 481
2017
Q1
$14.3M Sell
236,638
-226,473
-49% -$13.7M 0.02% 691
2016
Q4
$26M Sell
463,111
-280,340
-38% -$16.4M 0.03% 486
2016
Q3
$44.3M Buy
743,451
+415,322
+127% +$24.3M 0.05% 282
2016
Q2
$18M Buy
328,129
+43,911
+15% +$2.34M 0.02% 561
2016
Q1
$14.1M Sell
284,218
-160,868
-36% -$7.88M 0.02% 613
2015
Q4
$22.1M Sell
445,086
-2,389,440
-84% -$120M 0.03% 536
2015
Q3
$133M Buy
2,834,526
+2,227,524
+367% +$118M 0.16% 102
2015
Q2
$32.4M Sell
607,002
-703,312
-54% -$39.4M 0.04% 441
2015
Q1
$71.3M Sell
1,310,314
-293,860
-18% -$16.6M 0.08% 224
2014
Q4
$85.7M Buy
1,604,174
+606,164
+61% +$33.8M 0.08% 196
2014
Q3
$56.2M Buy
998,010
+516,664
+107% +$29M 0.05% 292
2014
Q2
$26.2M Buy
481,346
+35,736
+8% +$1.95M 0.03% 561
2014
Q1
$23.8M Sell
445,610
-2,259,592
-84% -$117M 0.03% 596
2013
Q4
$129M Buy
2,705,202
+1,000,211
+59% +$45.7M 0.13% 114
2013
Q3
$76.5M Sell
1,704,991
-527,878
-24% -$24.1M 0.09% 184
2013
Q2
$99M Buy
+2,232,869
New +$99.7M 0.12% 114

Other funds holding MRK

Barclays's MRK Position: Q1 2026 in Review

Barclays increased its Merck (MRK) stake by 58% in Q1 2026, buying an estimated $321M and bringing the position to 7,557,518 shares worth $909M. The position accounts for 0.22% of the portfolio, ranked #64.

Barclays first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.14B in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Barclays held 7,557,518 shares of Merck worth $909M as of Q1 2026.
  • Barclays bought 2,783,832 Merck shares in Q1 2026, an estimated $321M.
  • Merck made up 0.22% of Barclays's portfolio in Q1 2026, its #64 holding.
  • Barclays first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Merck position peaked at $1.14B in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.